Distribution of human papillomavirus types in anogenital warts of men

被引:54
作者
Chan, Paul K. S. [1 ]
Luk, Alfred C. S. [1 ]
Luk, Tommy N. M. [2 ,3 ]
Lee, Kwong-Fai [3 ]
Cheung, Jo L. K. [1 ]
Ho, King-Man [3 ]
Lo, Kuen-Kong [3 ]
机构
[1] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dermatol Res Ctr, Shatin, Hong Kong, Peoples R China
[3] Ctr Hlth Protect, Social Hyg Serv, Dept Hlth, Hong Kong, Hong Kong, Peoples R China
关键词
Human papillomavirus; Genotype; Anogenital wart; Male; Hong Kong; Vaccine; Condylomata accuminata; GRADE CERVICAL LESIONS; QUADRIVALENT VACCINE; PARTICLE VACCINE; CHINESE WOMEN; HPV INFECTION; CANCER; PREVALENCE; METAANALYSIS; AMPLIFICATION; EPIDEMIOLOGY;
D O I
10.1016/j.jcv.2008.11.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: A wide spectrum of human papillomavirus (HPV) types can infect the male genitalia. An HPV vaccine covering HPV6 and 11 is now available. Detailed data on the distribution of these two types in anogenital warts is needed to assess the potential benefits of the vaccine. Study design: Anogenital wart specimens collected from 130 Chinese men were examined for HPV-type distribution by a method that covers a broad spectrum of high- and low-risk HPVs, and able to reveal multiple types from a single specimen. Results: Forty-four (33.8%) of the 130 specimens had a coinfection with multiple HPV types. In 63.1% of cases, only HPV6 and/or HPV11 were/was found. In 26.2% of cases, HPV6 and/or HPV11 were/was found together with one or more other HPV types. In 10.8% of specimens, only non-6/11 HPV types were found. HPV16 and/or 18 were/was found in 12 (9.2%) specimens, with majority (8/12,66.7%) of which existed as coinfections with HPV6/11. Other HPV types found included HPV39,51, 52, 55, 59, 61, 62, 68, 58, 72, 81, 83, 84 and CP6108. Conclusions: A substantial proportion of HPV6/11-positive male anogenital warts are coinfected with other HPV types. The efficacy of HPV6/11 vaccine for preventing these lesions needs to be defined before the benefits of vaccinating men can be precisely assessed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:111 / 114
页数:4
相关论文
共 29 条
[11]   Prevalence of HPV infection among men: A systematic review of the literature [J].
Dunne, Eileen F. ;
Nielson, Carrie M. ;
Stone, Katherine M. ;
Markowitz, Lauri E. ;
Giuliano, Anna R. .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08) :1044-1057
[12]   Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases [J].
Garland, Suzanne M. ;
Hernandez-Avila, Mauricio ;
Wheeler, Cosette M. ;
Perez, Gonzalo ;
Harper, Diane M. ;
Leodolter, Sepp ;
Tang, Grace W. K. ;
Ferris, Daron G. ;
Steben, Marc ;
Bryan, Janine ;
Taddeo, Frank J. ;
Railkar, Radha ;
Esser, Mark T. ;
Sings, Heather L. ;
Nelson, Micki ;
Boslego, John ;
Sattler, Carlos ;
Barr, Eliav ;
Koutsky, Laura A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1928-1943
[13]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
[14]   Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial [J].
Harper, DM ;
Franco, EL ;
Wheeler, CM ;
Moscicki, AB ;
Romonowski, B ;
Roteli-Martins, CM ;
Jenkins, D ;
Schuind, A ;
Clemens, SAC ;
Dubin, G .
LANCET, 2006, 367 (9518) :1247-1255
[15]   EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION [J].
KOUTSKY, LA ;
GALLOWAY, DA ;
HOLMES, KK .
EPIDEMIOLOGIC REVIEWS, 1988, 10 :122-163
[16]   Epidemiologic classification of human papillomavirus types associated with cervical cancer [J].
Muñoz, N ;
Bosch, FX ;
de Sanjosé, S ;
Herrero, R ;
Castellsagué, X ;
Shah, KV ;
Snijders, PJF ;
Meijer, CJLM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :518-527
[17]   Cost-effectiveness analyses of human papillomavirus vaccination [J].
Newall, Anthony T. ;
Beutels, Philippe ;
Wood, James G. ;
Edmunds, W. John ;
MacIntyre, C. Raina .
LANCET INFECTIOUS DISEASES, 2007, 7 (04) :289-296
[18]   Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial [J].
Paavonen, Jorma ;
Jenkins, David ;
Bosch, F. Xavier ;
Naud, Paulo ;
Salmeron, Jorge ;
Wheeler, Cosette M. ;
Chow, Song-Nan ;
Apter, Dan L. ;
Kitchener, Henry C. ;
Castellsague, Xavier ;
de Carvalho, Newton S. ;
Skinner, S. Rachel ;
Harper, Diane M. ;
Hedrick, James A. ;
Jaisamrarn, Unnop ;
Limson, Genara A. M. ;
Dionne, Marc ;
Quint, Wim ;
Spiessens, Bart ;
Peeters, Pascal ;
Struyf, Frank ;
Wieting, Susan L. ;
Lehtinen, Matti O. ;
Dubin, Gary .
LANCET, 2007, 369 (9580) :2161-2170
[19]   HPV infection in men [J].
Palefsky, Joel M. .
DISEASE MARKERS, 2007, 23 (04) :261-272
[20]   Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students [J].
Partridge, Jeffrey M. ;
Hughes, James P. ;
Feng, Qinghua ;
Winer, Rachel L. ;
Weaver, Bethany A. ;
Xi, Long-Fu ;
Stern, Michael E. ;
Lee, Shu-Kuang ;
O'Reilly, Sandra F. ;
Hawes, Stephen E. ;
Kiviat, Nancy B. ;
Koutsky, Laura A. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (08) :1128-1136